Phenotyping Before Starting Treatment in COPD? - Test2 - elhamkhani - TriplyDB

Phenotyping Before Starting Treatment in COPD?

Phenotyping Before Starting Treatment in COPD?

http://www.wikidata.org/entity/Q39226768

about

Practical considerations when prescribing a long-acting muscarinic antagonist for patients with COPD.

P2860

Q55120067-B11EA154-132E-452C-A37B-F69FE7EF7CF0

P2860

Phenotyping Before Starting Treatment in COPD?

http://www.wikidata.org/entity/Q39226768

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Phenotyping Before Starting Treatment in COPD?

@en

Phenotyping Before Starting Treatment in COPD?

@nl

type

label

Phenotyping Before Starting Treatment in COPD?

@en

Phenotyping Before Starting Treatment in COPD?

@nl

prefLabel

Phenotyping Before Starting Treatment in COPD?

@en

Phenotyping Before Starting Treatment in COPD?

@nl

P1433

Q39226768-67252359-1A28-4DCF-B459-413CA8D6DB71

P1476

Q39226768-F8A36321-B9C5-42DA-BE6F-CB73A4448A76

P2093

Q39226768-02FABB12-C43D-40EA-9709-2EB0D7E31DEB

Q39226768-72B1F539-02E6-43C3-9F38-941CB3A7EEB6

P2860

Q39226768-0074FDB2-1A6A-420F-A97B-C85737B0180A

Q39226768-008CE351-10AA-4E61-99C5-BDB23C3FF2DD

Q39226768-00BCA457-E817-4C94-A039-8BC65F7E726D

Q39226768-00DE9710-FEAF-45B9-A206-81A07C8B6EB5

Q39226768-01BCD44C-A34B-4C92-8BF5-E8693EDAD3D1

Q39226768-0764B1D4-DB84-439A-9F2C-F40DE55744AF

Q39226768-0AFCA40B-CA87-47D2-BCF2-4EC0669ADA36

Q39226768-0BD18705-5F0B-419C-AAFB-80AAF9E502C3

Q39226768-102619C9-90E9-4CCB-B367-87B465683F0B

Q39226768-10855FE0-D420-4F1E-A067-2B18DADB5401

P304

Q39226768-87C8F7CC-6E66-4437-9C36-F76839B3AB9B

P31

Q39226768-C49FC842-0B38-468A-9E7C-5E8888873F3C

P356

Q39226768-489DCE50-8861-4A70-A07F-1405D57EB6A9

P407

Q39226768-71060A13-BE04-4DBC-837C-604D9B5DCA4F

P433

Q39226768-983BA9A7-7B08-45CC-B3D4-619469F0AFD0

P478

Q39226768-CDCCAF44-5987-4CDE-8BFA-86AFB73A9DEC

P50

Q39226768-7189A9B9-5240-48D5-95B9-83EB101CB172

P577

Q39226768-1AFA21B7-241D-49C6-B09E-257DD1244922

P698

Q39226768-69591180-B73A-4421-A0FA-A3B86A2141B7

P356

15412555.2017.1303041

P1433

COPD: Journal of Chronic Obstructive Pulmonary Disease

P1476

Phenotyping Before Starting Treatment in COPD?

@en

P2093

Evangelia Fouka

http://www.w3.org/2001/XMLSchema#string

Nikolaos Siafakas

http://www.w3.org/2001/XMLSchema#string

P2860

Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function

Chronic bronchitis and chronic obstructive pulmonary disease

New combination bronchodilators for chronic obstructive pulmonary disease: current evidence and future perspectives

A review of national guidelines for management of COPD in Europe

Histone acetylation and deacetylation: importance in inflammatory lung diseases

Genome-wide association study of smoking behaviours in patients with COPD

Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper

DNA methylation and human disease

Derivation and validation of clinical phenotypes for COPD: a systematic review.

Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials.

P304

367-374

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/15412555.2017.1303041

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Alexandru Corlateanu

P577

2017-04-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28388265

http://www.w3.org/2001/XMLSchema#string